APA (7th ed.) Citation

MA, A., H, K., LJ, A., M, J., & Y, M. (2018). The Photosensitising Clinical Agent Verteporfin Is an Inhibitor of SPAK and OSR1 Kinases. Chembiochem : a European journal of chemical biology, 19(19), 2072. https://doi.org/10.1002/cbic.201800272

Chicago Style (17th ed.) Citation

MA, AlAmri, Kadri H, Alderwick LJ, Jeeves M, and Mehellou Y. "The Photosensitising Clinical Agent Verteporfin Is an Inhibitor of SPAK and OSR1 Kinases." Chembiochem : A European Journal of Chemical Biology 19, no. 19 (2018): 2072. https://doi.org/10.1002/cbic.201800272.

MLA (9th ed.) Citation

MA, AlAmri, et al. "The Photosensitising Clinical Agent Verteporfin Is an Inhibitor of SPAK and OSR1 Kinases." Chembiochem : A European Journal of Chemical Biology, vol. 19, no. 19, 2018, p. 2072, https://doi.org/10.1002/cbic.201800272.